Paper3865632
Cefotiam therapy of lower respiratory tract infections.
Polis MA and 1 other. Antimicrob Agents Chemother, 1985. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cefotiam therapy of lower respiratory tract infections. Papers, record 3865632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3865632
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cefotaxime | Major topic |
| Respiratory Tract Infections | Major topic |
| Adult | |
| Aged | |
| Cefotiam | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,325,707 | Antibiotic susceptibility testing by a standardized single disk method. | Am J Clin Pathol | 1966 | https://conductscience.org/library/papers/5325707 | PubMed |
| 2 | 4,893,892 | Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. | J Infect Dis | 1969 | https://conductscience.org/library/papers/4893892 | PubMed |
| 3 | 1,127,999 | Microscopic and baceriologic analysis of expectorated sputum. | Mayo Clin Proc | 1975 | https://conductscience.org/library/papers/1127999 | PubMed |
| 4 | 718,154 | SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/718154 | PubMed |
| 5 | 6,331,302 | Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6331302 | PubMed |
| 6 | 371,539 | SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/371539 | PubMed |
| 7 | 395,155 | Comparison of cefotiam and cefazolin activity against Gram-negative bacilli. | J Antimicrob Chemother | 1979 | https://conductscience.org/library/papers/395155 | PubMed |
| 8 | 6,294,043 | In-vitro activity of cefotiam against bacteria of clinical interest. | J Antimicrob Chemother | 1982 | https://conductscience.org/library/papers/6294043 | PubMed |
| 9 | 738,967 | Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs. | J Antibiot (Tokyo) | 1978 | https://conductscience.org/library/papers/738967 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 24,764,924 | 1-[2-(Di-methyl-aza-nium-yl)eth-yl]-1H-1,2,3,4-tetra-zole-5-thiol-ate. | Acta Crystallogr Sect E Struct Rep Online | 2014 | https://conductscience.org/library/papers/24764924 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3865632
GET https://conductscience.org/api/papers/v1/3865632/authors